ロード中...
Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye
PURPOSE: Dry eye is a chronic inflammatory ocular surface disease with high prevalence. The current therapies for dry eye remain to be unspecific and notcomprehensive. This study aims to explore safety and efficacy of a novel treatment – subconjunctival injection of bevacizumab – in dry eye patients...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4472070/ https://ncbi.nlm.nih.gov/pubmed/26109847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S85529 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|